Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ro is a direct-to-patient healthcare company that integrates telehealth, diagnostics, and pharmacy services into a single vertical platform. Originally launched as Roman, a men's health brand, the company has expanded to provide care for women (Rory) and general health concerns, including weight management and smoking cessation. Ro's business model focuses on increasing accessibility to treatment for common conditions like erectile dysfunction, hair loss, and obesity by providing end-to-end clinical care from consultation to medication delivery. The company has recently gained significant traction in the metabolic health space by offering access to GLP-1 receptor agonists through its Body Program.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Roman Industries.